Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.44
-0.39 (-2.46%)
At close: Mar 6, 2026, 4:00 PM EST
15.26
-0.18 (-1.15%)
After-hours: Mar 6, 2026, 4:10 PM EST
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.06 billion as of March 6, 2026. Its market cap has increased by 67.66% in one year.
Market Cap
1.06B
Enterprise Value
1.02B
1-Year Change
67.66%
Ranking
Category
Stock Price
$15.44
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.06B, an increase of 720.22%. That is a compound annual growth rate of 8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.07B | -6.69% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.20B |
| Inventiva | 1.17B |
| Precigen | 1.15B |
| ArriVent BioPharma | 1.08B |
| AbCellera Biologics | 1.04B |
| Aktis Oncology | 1.03B |
| Inhibrx Biosciences | 1.01B |
| Geron | 1.00B |